- likes
- 74
- comments
- 0
Post
Why choose between tissue and liquid biopsy when both could provide critical insights? The MI Cancer Seek® platform delivers comprehensive tumor profiling, including key mutations, fusions, protein expression, TMB, GPSai® and companion diagnostic indications. Caris Assure® adds a rapid, real-time view of circulating tumor DNA and tumor evolution while distinguishing tumor-derived alterations from clonal hematopoiesis. Concurrent testing provides a more complete molecular picture to help guide treatment decisions from the start. Learn more: https://ow.ly/QB4B50ZjHOo